Your browser doesn't support javascript.
loading
Three new coumarin derivatives from Maytenus hookeri.
Meng, Lingjie; Yu, Changyan; Hui, Jing; Jiang, Nian; Wang, Haijuan; Xie, Jianxun; Xu, Lin; Liu, Yun.
Afiliação
  • Meng L; Guizhou Provincial College-based Key Lab for Tumor Prevention and Treatment with Distinctive Medicines, Zunyi Medical University, Zunyi, China.
  • Yu C; Institute of Life Sciences, Zunyi Medical University, Zunyi, China.
  • Hui J; College of Basic Medicine, Zunyi Medical University, Zunyi, China.
  • Jiang N; Guizhou Provincial College-based Key Lab for Tumor Prevention and Treatment with Distinctive Medicines, Zunyi Medical University, Zunyi, China.
  • Wang H; Institute of Life Sciences, Zunyi Medical University, Zunyi, China.
  • Xie J; College of Basic Medicine, Zunyi Medical University, Zunyi, China.
  • Xu L; Guizhou Provincial College-based Key Lab for Tumor Prevention and Treatment with Distinctive Medicines, Zunyi Medical University, Zunyi, China.
  • Liu Y; Institute of Life Sciences, Zunyi Medical University, Zunyi, China.
Nat Prod Res ; : 1-7, 2022 Sep 16.
Article em En | MEDLINE | ID: mdl-36111662
ABSTRACT
Three new coumarin derivatives named maytenucoums A-C (1-3), along with six known analogs (4-9), were isolated from the branches of Maytenus hookeri. Their structures were determined by comprehensive spectroscopic data analysis, including NMR and HR-ESIMS. In the preliminary assays, compound 4 showed cytotoxic activity against the A549, SK-Hep1 and HCT116 cells with IC50 values of 29.0, 28.6 and 54.4 µM, respectively.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article